je.st
news
Ligand Pharmaceutica PT Raised to $26.00 at Cantor Fitzgerald
2013-03-23 21:53:55| Biotech - Topix.net
The firm currently has a "hold" rating on the stock. The analysts wrote, "On March 14 the company announced its license and global supply agreement with Spectrum Pharmaceuticals on Captisol-enabled Melphalan for the treatment of multiple myeloma.
Tags: raised
fitzgerald
cantor
ligand
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||